It is known that the chronic inflammatory status is a common characteristic in HF and CKD and is responsible for ESA hyporesponsiveness in this category of patients, who require a high dose of ESA to obtain an EPO level that could increase hemoglobin. The gene discussed is EPO; the disease is hydrops fetalis.